The role of Ube3a in neuronal development

Detalhes bibliográficos
Autor(a) principal: Resende, Carlos Manuel dos Santos
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/33367
Resumo: Angelman syndrome (AS) is a genetic disorder characterized by paternal imprinting and maternal deletion of Ube3a. Therefore AS patients have reduced levels of expression of Ube3a in several regions of the brain including the hippocampus and cerebellum. AS patients have motor impairment, mental retardation and absence of speech. Ube3a is an E3 ligase responsible for the ubiquitination of protein leading to the proteasomal degradation and the lack of function as been associated with loss of synaptic plasticity. Although there’s been the identification of several Ube3a substrates with important role in the postsynapse the role of presynaptic Ube3a and the symptoms found in AS patients is still not clear. Ube3a transcription is induced by synaptic activity and glutamate release during early stages of development, indicating that neuronal excitability is important to regulate Ube3a activity. Nonetheless, Ube3a role in excitatory synapse formation and maturation is still not clear. In this work we did a subcellular characterization of Ube3a expression in several regions of Rat and Mouse hippocampal neurons. We observed that Ube3a is expressed at high levels within the nucleus of hippocampal neurons but is also present in the cytoplasm and along the axon. Our results show that Ube3a is highly expressed in the presynaptic compartments of neurons in early stages of development followed by a decrease in the later stages of development. Furthermore, we show that expressing a catalytic inactive form of Ube3a in rat embryonic hippocampal neurons disrupts synapse formation and maturation. Our data suggests that Ube3a catalytic function is necessary for promoting excitatory synapse formation. Collectively, these data contributes to a deeper understanding of the cognitive alterations found in patients with Angelman Syndrome.
id RCAP_cf531f2378c006febfb76db7c0b5d05d
oai_identifier_str oai:ria.ua.pt:10773/33367
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The role of Ube3a in neuronal developmentAngelman syndromeUbe3aProteasomal degradationNeurodevelopmentSynaptic activityExcitatory synapseAngelman syndrome (AS) is a genetic disorder characterized by paternal imprinting and maternal deletion of Ube3a. Therefore AS patients have reduced levels of expression of Ube3a in several regions of the brain including the hippocampus and cerebellum. AS patients have motor impairment, mental retardation and absence of speech. Ube3a is an E3 ligase responsible for the ubiquitination of protein leading to the proteasomal degradation and the lack of function as been associated with loss of synaptic plasticity. Although there’s been the identification of several Ube3a substrates with important role in the postsynapse the role of presynaptic Ube3a and the symptoms found in AS patients is still not clear. Ube3a transcription is induced by synaptic activity and glutamate release during early stages of development, indicating that neuronal excitability is important to regulate Ube3a activity. Nonetheless, Ube3a role in excitatory synapse formation and maturation is still not clear. In this work we did a subcellular characterization of Ube3a expression in several regions of Rat and Mouse hippocampal neurons. We observed that Ube3a is expressed at high levels within the nucleus of hippocampal neurons but is also present in the cytoplasm and along the axon. Our results show that Ube3a is highly expressed in the presynaptic compartments of neurons in early stages of development followed by a decrease in the later stages of development. Furthermore, we show that expressing a catalytic inactive form of Ube3a in rat embryonic hippocampal neurons disrupts synapse formation and maturation. Our data suggests that Ube3a catalytic function is necessary for promoting excitatory synapse formation. Collectively, these data contributes to a deeper understanding of the cognitive alterations found in patients with Angelman Syndrome.Síndrome de Angelman é uma doença genética caracterizada por imprinting paternal e deleção maternal da Ube3a. Deste modo, pacientes com Síndrome de Angelman têm níveis reduzidos de expressão da Ube3a em várias regiões do cérebro, incluindo o hipocampo e o cerebelo. Pacientes com Síndrome de Angelman apresentam dificuldades motoras, retardação mental e ausência de fala. Ube3a é uma E3 ligase responsável pela ubiquitinação de proteínas levando a degradação proteasomal dessas proteínas e a perda de função tem sido associada com perda de plasticidade sináptica. Ainda que tenham sido identificados vários substratos desta proteína com um papel pós sináptico importante o seu papel a nível pré sináptico e a correlação com os sintomas encontrados ainda não é clara. A transcrição da Ube3a é induzida por atividade sináptica e libertação de glutamato durante os primeiros estágios de desenvolvimento indicando que a atividade da Ube3a é importante para regular a excitabilidade neuronal. Apesar disso, o papel desta proteína na formação e maturação das sinapses excitatórias é ainda desconhecido. Neste trabalho realizamos uma caracterização da expressão desta proteína em várias regiões dos neurónios do hipocampo de duas espécies de rato (Mus musculus) e (Rattus norvegicus). Nós observamos que a Ube3a está expressa em elevados níveis nos núcleos dos neurónios em estágio de desenvolvimento iniciais, mas está também expressa no citoplasma e axónios. Os nossos resultados mostram que esta proteína está altamente expressa pré-sinapticamente tendo maior presença em estágios de desenvolvimento inicias seguido de um decréscimo em estágios de desenvolvimento tardios. Além disso, demonstramos que expressar neurónios do hipocampo de Rato com uma proteína cataliticamente inativa perturba a formação e maturação de sinapses. Estes dados indicam que a função catalítica da Ube3a é necessária para promover a formação de sinapses excitatórias. Coletivamente, estes dados podem explicar as alterações cognitivas encontradas em pacientes com Síndrome de Angelman.2023-12-20T00:00:00Z2021-12-09T00:00:00Z2021-12-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/33367engResende, Carlos Manuel dos Santosinfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T12:04:09Zoai:ria.ua.pt:10773/33367Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:04:47.530276Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The role of Ube3a in neuronal development
title The role of Ube3a in neuronal development
spellingShingle The role of Ube3a in neuronal development
Resende, Carlos Manuel dos Santos
Angelman syndrome
Ube3a
Proteasomal degradation
Neurodevelopment
Synaptic activity
Excitatory synapse
title_short The role of Ube3a in neuronal development
title_full The role of Ube3a in neuronal development
title_fullStr The role of Ube3a in neuronal development
title_full_unstemmed The role of Ube3a in neuronal development
title_sort The role of Ube3a in neuronal development
author Resende, Carlos Manuel dos Santos
author_facet Resende, Carlos Manuel dos Santos
author_role author
dc.contributor.author.fl_str_mv Resende, Carlos Manuel dos Santos
dc.subject.por.fl_str_mv Angelman syndrome
Ube3a
Proteasomal degradation
Neurodevelopment
Synaptic activity
Excitatory synapse
topic Angelman syndrome
Ube3a
Proteasomal degradation
Neurodevelopment
Synaptic activity
Excitatory synapse
description Angelman syndrome (AS) is a genetic disorder characterized by paternal imprinting and maternal deletion of Ube3a. Therefore AS patients have reduced levels of expression of Ube3a in several regions of the brain including the hippocampus and cerebellum. AS patients have motor impairment, mental retardation and absence of speech. Ube3a is an E3 ligase responsible for the ubiquitination of protein leading to the proteasomal degradation and the lack of function as been associated with loss of synaptic plasticity. Although there’s been the identification of several Ube3a substrates with important role in the postsynapse the role of presynaptic Ube3a and the symptoms found in AS patients is still not clear. Ube3a transcription is induced by synaptic activity and glutamate release during early stages of development, indicating that neuronal excitability is important to regulate Ube3a activity. Nonetheless, Ube3a role in excitatory synapse formation and maturation is still not clear. In this work we did a subcellular characterization of Ube3a expression in several regions of Rat and Mouse hippocampal neurons. We observed that Ube3a is expressed at high levels within the nucleus of hippocampal neurons but is also present in the cytoplasm and along the axon. Our results show that Ube3a is highly expressed in the presynaptic compartments of neurons in early stages of development followed by a decrease in the later stages of development. Furthermore, we show that expressing a catalytic inactive form of Ube3a in rat embryonic hippocampal neurons disrupts synapse formation and maturation. Our data suggests that Ube3a catalytic function is necessary for promoting excitatory synapse formation. Collectively, these data contributes to a deeper understanding of the cognitive alterations found in patients with Angelman Syndrome.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-09T00:00:00Z
2021-12-09
2023-12-20T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/33367
url http://hdl.handle.net/10773/33367
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137703423377408